DD297556A5 - Verfahren zur herstellung eines komplexierten arzneimittels - Google Patents

Verfahren zur herstellung eines komplexierten arzneimittels Download PDF

Info

Publication number
DD297556A5
DD297556A5 DD90343976A DD34397690A DD297556A5 DD 297556 A5 DD297556 A5 DD 297556A5 DD 90343976 A DD90343976 A DD 90343976A DD 34397690 A DD34397690 A DD 34397690A DD 297556 A5 DD297556 A5 DD 297556A5
Authority
DD
German Democratic Republic
Prior art keywords
polymer
active ingredient
water
acid
mixture
Prior art date
Application number
DD90343976A
Other languages
German (de)
English (en)
Inventor
Andreas Vincze
Manfred Assmus
Hans-Ulrich Petereit
Original Assignee
��������@��������@����������@���k��
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ��������@��������@����������@���k�� filed Critical ��������@��������@����������@���k��
Publication of DD297556A5 publication Critical patent/DD297556A5/de

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent

Landscapes

  • Health & Medical Sciences (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
DD90343976A 1989-09-14 1990-09-12 Verfahren zur herstellung eines komplexierten arzneimittels DD297556A5 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE3930733A DE3930733A1 (de) 1989-09-14 1989-09-14 Verfahren zur herstellung eines komplexierten arzneimittels

Publications (1)

Publication Number Publication Date
DD297556A5 true DD297556A5 (de) 1992-01-16

Family

ID=6389432

Family Applications (1)

Application Number Title Priority Date Filing Date
DD90343976A DD297556A5 (de) 1989-09-14 1990-09-12 Verfahren zur herstellung eines komplexierten arzneimittels

Country Status (6)

Country Link
EP (1) EP0417588B1 (fr)
JP (1) JPH03109333A (fr)
AT (1) ATE79551T1 (fr)
DD (1) DD297556A5 (fr)
DE (2) DE3930733A1 (fr)
HU (1) HU217957B (fr)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69419281T2 (de) * 1993-04-28 2000-03-23 Takeda Chemical Industries, Ltd. Geschmacksmaskierte feste Zubereitung und Verfahren zur Herstellung
IL113812A (en) 1994-05-24 2000-06-29 Yeda Res & Dev Copolymer-1 pharmaceutical compositions containing it and its use
DE19631084A1 (de) 1996-08-01 1998-02-05 Basf Ag Verwendung von (Meth)acrylsäure-Copolymeren zur Erhöhung der Permeabilität der Schleimhaut
WO2000005250A1 (fr) 1998-07-23 2000-02-03 Yeda Research And Development Co., Ltd Traitement de maladies auto-immunes a l'aide du copolymere 1 et des copolymeres et peptides apparentes
ES2527760T3 (es) 1998-07-23 2015-01-29 Yeda Research And Development Co., Ltd. Tratamiento de enfermedad de Crohn con copolímero 1 y polipéptidos
US6800287B2 (en) 1998-09-25 2004-10-05 Yeda Research And Development Co., Ltd. Copolymer 1 related polypeptides for use as molecular weight markers and for therapeutic use
CA2469393C (fr) 2001-12-04 2010-05-25 Teva Pharmaceutical Industries, Ltd. Procedes pour mesurer la puissance de l'acetate de glatiramer
DE10304403A1 (de) 2003-01-28 2004-08-05 Röhm GmbH & Co. KG Verfahren zur Herstellung einer oralen Arzneiform mit unmittelbarem Zerfall und Wirkstofffreisetzung
NZ554018A (en) 2004-09-09 2009-06-26 Teva Pharma Process for preparation of trifluoroacetyl glatiramer acetate using purified hydrobromic acid
DK1797109T3 (en) 2004-09-09 2016-04-11 Yeda Res & Dev MIXTURES OF POLYPEPTIDES, compositions containing them and methods for their preparation, and uses thereof
WO2006050122A1 (fr) 2004-10-29 2006-05-11 Sandoz Ag Procedes de preparation d'un glatiramere

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA927282A (en) * 1968-09-03 1973-05-29 S. Banker Gilbert Entrapment compositions and processes
DE2752705A1 (de) * 1977-11-25 1979-05-31 Egyt Gyogyszervegyeszeti Gyar Depotarzneimittelpraeparate
US4539199A (en) * 1981-01-14 1985-09-03 Egyt Gyogyszervegyeszeti Gyar Sustained release pharmaceutical compositions
CH664284A5 (en) * 1985-07-08 1988-02-29 Arcopharma Sa Chloroquine medicaments without bitter taste - contain complex of chloroquine with copolymer of methacrylic] acid and methyl methacrylate]

Also Published As

Publication number Publication date
HU905897D0 (en) 1991-03-28
JPH03109333A (ja) 1991-05-09
HUT61457A (en) 1993-01-28
ATE79551T1 (de) 1992-09-15
HU217957B (hu) 2000-05-28
EP0417588A2 (fr) 1991-03-20
DE59000267D1 (de) 1992-09-24
DE3930733A1 (de) 1991-03-28
EP0417588A3 (en) 1991-07-10
EP0417588B1 (fr) 1992-08-19

Similar Documents

Publication Publication Date Title
EP0181515B1 (fr) Procédé pour la préparation d'une dispersion aqueuse d'un produit d'enrobage et son utilisation pour enrober des compositions pharmaceutiques
EP0058765B1 (fr) Enrobage soluble ou gonflable dans le suc gastrique, son utilisation dans un procédé d'enrobage de formes pharmaceutiques
DE60101468T2 (de) Direktkomprimierte partikel für feste darreichungsformen
DE69022452T2 (de) Direktkomprimierte Cholestyramintablette und lösungsmittelfreier Überzug dafür.
EP0122219B1 (fr) Résines d'acides carboxyliques substitués, leur procédé de préparation, leur application et compositions pharmaceutiques contenant ces résines
DE3877764T2 (de) Ein freifliessendes granulat, enthaltend ibuprofen und ein herstellunsgverfahren.
DE2400819C2 (de) Verfahren zur Herstellung fester Zubereitungen von schwerlöslichen Arzneimittelwirkstoffen in feinster Verteilung
DE69001488T2 (de) Mittel auf gemfibrozilbasis mit modifizierter freigabe.
EP0545209B1 (fr) Poudres de dispersion redispersable d'un copolymère de N-vinylpyrrolidone et d'acétate de vinyle, leur préparation et usage
EP0164669A2 (fr) Procédé pour enrober des formes pharmaceutiques
DE3314003A1 (de) Teilbare tablette mit verzoegerter wirkstofffreigabe und verfahren zu deren herstellung
CH672736A5 (fr)
DE69530421T2 (de) Stärkeacetatpräparat mit modifizierbaren eigenschaften, verfahren für seine herstellung und verwendung
WO2016015812A1 (fr) Polyalcools de vinyle aptes à la compression directe
DE69001487T2 (de) Gemfibrozil enthaltende mittel mit verlaengerter freigabe.
DE3431861A1 (de) Pellet-zubereitung
DE4220782A1 (de) Verfahren zur Herstellung von festen pharmazeutischen Retardformen
EP0417588B1 (fr) Procédé pour la préparation d'un médicament complexé
DE69813872T2 (de) Komplex aus carrageenan und einem wasserlöslichen medikament mit einer spezifischen granulometrie und entsprechende pharmazeutische zusammensetzungen mit gesteuerter freisetzung
DE69011836T2 (de) Verfahren zur Hestellung von Tabletten, die sprühgetrocknetes Naproxen oder Naproxen Natriumsalz enthalten.
EP1250132A1 (fr) Preparation a principe actif ibuprofene
AT500135A1 (de) Organische verbindungen
DE69609501T2 (de) Zusammensetzung mit natriumstärkeglycolat als grundlagenmaterial und daraus hergestellte produkte
EP0721785A2 (fr) Préparation de ranitidin désamerisée
EP0536595B1 (fr) Procédé pour enrober des formes pharmaceutiques

Legal Events

Date Code Title Description
ENJ Ceased due to non-payment of renewal fee